• Work on Pulmatrix’s PUR1900 for Fungal Infections in CF Patients Bolstered by FDA
  • First Patients Dosed in Phase 2 Test of Lynovex for CF Exacerbations
  • Enzyme That Degrades Biofilm May Be Key to Treating Pseudomonas Lung Infection in CF
  • Potentially Dangerous Bacterial Infection May Be Common in CF, But Few Show Symptoms
  • Patients, Parents Fearful of Initial Bacterial Lung Infection, Survey Finds
  • First Allied Securities Donates $73,000 to Cystic Fibrosis Foundation
  • CF Foundation Grant to Support Testing of Bacterial Lung Infection Treatment
  • Annual Rate of Hospitalization, In-Hospital Deaths Up in US, Study Finds
  • Dutch Validation Trial to Test Use of ‘Organoids’ in Studying CF Therapies
  • Catabasis Aims for Phase 1 Trial of Cystic Fibrosis Therapy with Convincing Preclinical Data
  • AIR DNase Seen to Help Clear Mucus from CF Patients’ Lungs in Small Study
  • Phase 2 Study of Resunab in CF Patients Finished, Results Expected Soon